Table 4. Significantly related diseases of the gene targets (1802) of the 14 highly expressed miRNAs in milk fractions.
| Category | p-value | #Molecules |
|---|---|---|
| Cancer | 2.43E-84–3.79E-28 | 1668 |
| Organismal injury and abnormalities | 3.4E-73–3.79E-28 | 1677 |
| Infectious diseases | 7.99E-73–9.37E-29 | 374 |
| Developmental disorder | 1.5E-64–6.51E-33 | 590 |
| Reproductive system disease | 1.18E-62–4.22E-29 | 988 |
| Skeletal and muscular disorders | 8.46E-62–5.84E-30 | 694 |
| Hematological disease | 5.34E-59–1.39E-28 | 529 |
| Tumor morphology | 7.43E-58–2.18E-33 | 279 |
| Metabolic disease | 1.16E-55–3.55E-31 | 426 |
| Inflammatory response | 6.6E-53–1.03E-35 | 422 |
| Gastrointestinal disease | 1.74E-52–3.79E-28 | 1329 |
| Neurological disease | 6.11E-52–5.84E-30 | 564 |
| Cardiovascular disease | 3.54E-50–9.33E-31 | 287 |
| Connective tissue disorders | 4.49E-50–5.34E-42 | 402 |
| Inflammatory disease | 3.9E-44–7.21E-39 | 335 |
| Endocrine system disorders | 4.2E-43–5.67E-30 | 430 |
| Immunological disease | 1.7E-40–1.39E-28 | 482 |
| Nutritional disease | 3.21E-37–3.21E-37 | 150 |
| Psychological disorders | 6.16E-36–7.12E-29 | 354 |
| Hepatic system disease | 6.04E-34–3.79E-28 | 788 |
| Respiratory disease | 6.25E-34–5.25E-29 | 270 |
| Hereditary disorder | 6.89E-33–5.84E-30 | 287 |